Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1955 1
1957 1
1961 2
1962 2
1963 2
1964 2
1965 9
1966 2
1967 3
1968 4
1969 1
1970 4
1971 1
1972 1
1973 3
1974 2
1975 10
1976 3
1977 4
1978 6
1979 11
1980 13
1981 11
1982 11
1983 19
1984 13
1985 16
1986 19
1987 9
1988 8
1989 13
1990 11
1991 18
1992 15
1993 14
1994 17
1995 21
1996 17
1997 24
1998 29
1999 32
2000 35
2001 39
2002 37
2003 36
2004 42
2005 40
2006 44
2007 41
2008 59
2009 55
2010 58
2011 71
2012 71
2013 65
2014 75
2015 71
2016 80
2017 62
2018 65
2019 82
2020 89
2021 84
2022 84
2023 23
Text availability
Article attribute
Article type
Publication date

Search Results

1,641 results
Results by year
Filters applied: . Clear all
Page 1
Cell-matrix interface regulates dormancy in human colon cancer stem cells.
Ohta Y, Fujii M, Takahashi S, Takano A, Nanki K, Matano M, Hanyu H, Saito M, Shimokawa M, Nishikori S, Hatano Y, Ishii R, Sawada K, Machinaga A, Ikeda W, Imamura T, Sato T. Ohta Y, et al. Among authors: sawada k. Nature. 2022 Aug;608(7924):784-794. doi: 10.1038/s41586-022-05043-y. Epub 2022 Jul 7. Nature. 2022. PMID: 35798028
Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trial.
Nakamura Y, Okamoto W, Kato T, Esaki T, Kato K, Komatsu Y, Yuki S, Masuishi T, Nishina T, Ebi H, Sawada K, Taniguchi H, Fuse N, Nomura S, Fukui M, Matsuda S, Sakamoto Y, Uchigata H, Kitajima K, Kuramoto N, Asakawa T, Olsen S, Odegaard JI, Sato A, Fujii S, Ohtsu A, Yoshino T. Nakamura Y, et al. Among authors: sawada k. Nat Med. 2021 Nov;27(11):1899-1903. doi: 10.1038/s41591-021-01553-w. Epub 2021 Nov 11. Nat Med. 2021. PMID: 34764486 Free PMC article. Clinical Trial.
CIRCULATE-Japan: Circulating tumor DNA-guided adaptive platform trials to refine adjuvant therapy for colorectal cancer.
Taniguchi H, Nakamura Y, Kotani D, Yukami H, Mishima S, Sawada K, Shirasu H, Ebi H, Yamanaka T, Aleshin A, Billings PR, Rabinowitz M, Oki E, Takemasa I, Kato T, Mori M, Yoshino T. Taniguchi H, et al. Among authors: sawada k. Cancer Sci. 2021 Jul;112(7):2915-2920. doi: 10.1111/cas.14926. Epub 2021 Jun 7. Cancer Sci. 2021. PMID: 33931919 Free PMC article. Clinical Trial.
Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer.
Gao Q, Yang Z, Xu S, Li X, Yang X, Jin P, Liu Y, Zhou X, Zhang T, Gong C, Wei X, Liu D, Sun C, Chen G, Hu J, Meng L, Zhou J, Sawada K, Fruscio R, Grunt TW, Wischhusen J, Vargas-Hernández VM, Pothuri B, Coleman RL. Gao Q, et al. Among authors: sawada k. J Exp Med. 2019 Mar 4;216(3):688-703. doi: 10.1084/jem.20180765. Epub 2019 Feb 1. J Exp Med. 2019. PMID: 30710055 Free PMC article.
Identification of Quiescent LGR5+ Stem Cells in the Human Colon.
Ishikawa K, Sugimoto S, Oda M, Fujii M, Takahashi S, Ohta Y, Takano A, Ishimaru K, Matano M, Yoshida K, Hanyu H, Toshimitsu K, Sawada K, Shimokawa M, Saito M, Kawasaki K, Ishii R, Taniguchi K, Imamura T, Kanai T, Sato T. Ishikawa K, et al. Among authors: sawada k. Gastroenterology. 2022 Nov;163(5):1391-1406.e24. doi: 10.1053/j.gastro.2022.07.081. Epub 2022 Aug 11. Gastroenterology. 2022. PMID: 35963362 Free article.
Exosomal CD47 Plays an Essential Role in Immune Evasion in Ovarian Cancer.
Shimizu A, Sawada K, Kobayashi M, Yamamoto M, Yagi T, Kinose Y, Kodama M, Hashimoto K, Kimura T. Shimizu A, et al. Among authors: sawada k. Mol Cancer Res. 2021 Sep;19(9):1583-1595. doi: 10.1158/1541-7786.MCR-20-0956. Epub 2021 May 20. Mol Cancer Res. 2021. PMID: 34016744
Profiling the inhibitory receptors LAG-3, TIM-3, and TIGIT in renal cell carcinoma reveals malignancy.
Takamatsu K, Tanaka N, Hakozaki K, Takahashi R, Teranishi Y, Murakami T, Kufukihara R, Niwa N, Mikami S, Shinojima T, Sasaki T, Sato Y, Kume H, Ogawa S, Kakimi K, Kamatani T, Miya F, Tsunoda T, Aimono E, Nishihara H, Sawada K, Imamura T, Mizuno R, Oya M. Takamatsu K, et al. Among authors: sawada k. Nat Commun. 2021 Sep 20;12(1):5547. doi: 10.1038/s41467-021-25865-0. Nat Commun. 2021. PMID: 34545095 Free PMC article.
Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study.
Fujii H, Iwaki M, Hayashi H, Toyoda H, Oeda S, Hyogo H, Kawanaka M, Morishita A, Munekage K, Kawata K, Yamamura S, Sawada K, Maeshiro T, Tobita H, Yoshida Y, Naito M, Araki A, Arakaki S, Kawaguchi T, Noritake H, Ono M, Masaki T, Yasuda S, Tomita E, Yoneda M, Kawada N, Tokushige A, Kamada Y, Takahashi H, Ueda S, Aishima S, Sumida Y, Nakajima A, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Fujii H, et al. Among authors: sawada k. Clin Gastroenterol Hepatol. 2023 Feb;21(2):370-379. doi: 10.1016/j.cgh.2022.01.002. Epub 2022 Jan 17. Clin Gastroenterol Hepatol. 2023. PMID: 35051649
1,641 results